Fortune India features HRV Pharma for pioneering a capital‑efficient virtual pharma model that is transforming India’s bulk drug and API ecosystem through speed, compliance, and global regulatory execution.
India's rise in biosimilars & biologics. Full clipping + insights included.
HRV Pharma has been officially certified as a Great Place To Work® for 2025–2026, with multiple media outlets highlighting the company’s culture of trust, inclusivity, and employee empowerment.
HRV Pharma's CEO discusses how AI transforms pharmaceutical supply chains from reactive systems to anticipatory networks, ensuring continuous medicine availability through predictive intelligence.
HRV Pharma's CEO Hari Kiran Chereddi explores how digital intelligence and AI are transforming pharmaceutical supply chains from efficiency-driven models to resilient, adaptive networks.
HRV Global's Managing Director Hari Kiran Chereddi discusses India's transformation from volume-driven API supplier to value-oriented strategic partner, highlighting virtual pharma models and AI-driven operations.